{
    "clinical_study": {
        "@rank": "156478", 
        "arm_group": [
            {
                "arm_group_label": "sepsis", 
                "description": "sepsis defined as suspected infection and systemic inflammatory response"
            }, 
            {
                "arm_group_label": "severe sepsis", 
                "description": "sepsis with organ dysfunction or septic shock defined as sepsis plus hypotension"
            }, 
            {
                "arm_group_label": "control group", 
                "description": "control defined as non-infected patients without systemic inflammatory response."
            }
        ], 
        "biospec_descr": {
            "textblock": "plasma"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "To determine the plasma levels of mtDNA in ICU department patients with and without sepsis\n      and evaluate their association with severity, systemic inflammation and outcomes. Plasma\n      from control, septic and severe septic patients will be collected. The level of mtDNA and\n      systemic cytokine will be measured."
        }, 
        "brief_title": "Investigation of Plasma Mitochondrial DNA Level in Septic Patients", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Sepsis", 
            "Inflammation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Inflammation", 
                "Sepsis", 
                "Toxemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "Clinical protocol:\n\n      Patients were enrolled into one of three cohorts: (i) sepsis defined as suspected infection\n      and systemic inflammatory response, (ii) septic shock defined as sepsis plus hypotension,\n      and (iii) control defined as non-infected patients without systemic inflammatory response.\n\n      Methods:\n\n      Plasma levels of mtDNAs were measured using real-time quantitative polymerase chain\n      reaction. Levels of mtDNAs were compared among each group, and linear regression was used to\n      assess the association between mtDNAs, IL-6, TNF a and IL-1b in patients with sepsis. The\n      correlation between plasma mtDNA and severity, systemic inflammation and outcomes will be\n      analyzed."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of sepsis and severe sepsis was according to the following guild-line.\n             \"Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis\n             and Septic Shock: 2012\"\n\n        Exclusion Criteria:\n\n          -  Patients lost following-up. Patients who refuse to sign the consent form."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Sepsis and severe septic patients enrolled in 2014 will be collected."
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02019992", 
            "org_study_id": "CSU-ICU-2013-01"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "sepsis", 
            "mitochondrial DNA", 
            "systemic inflammation", 
            "outcome"
        ], 
        "lastchanged_date": "December 18, 2013", 
        "location": {
            "contact": {
                "last_name": "lemeng zhang, md", 
                "phone": "8673185064389"
            }, 
            "contact_backup": {
                "last_name": "yuhang ai, md", 
                "phone": "8673284327974"
            }, 
            "facility": {
                "address": {
                    "city": "Changsha", 
                    "country": "China", 
                    "state": "Hunan", 
                    "zip": "410000"
                }, 
                "name": "Xiangya Hospital"
            }, 
            "investigator": {
                "last_name": "lemeng zhang, md", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "3", 
        "official_title": "Plasma Levels of Mitochondrial DNA in Patients Presenting to ICU With Sepsis", 
        "overall_contact": {
            "last_name": "lemeng zhang, md", 
            "phone": "8673185064389"
        }, 
        "overall_contact_backup": {
            "last_name": "yuhang ai, ma", 
            "phone": "8673184327074"
        }, 
        "overall_official": {
            "affiliation": "Central South University", 
            "last_name": "lemeng zhang, md", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee, Central South University", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The change from baseline in plasma mtDNA in septic patients at 7 days will be measured by real-time PCR.", 
            "measure": "change from baseline in plasma mtDNA in septic patients at 7 days", 
            "safety_issue": "Yes", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02019992"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Central South University", 
            "investigator_full_name": "lemeng zhang", 
            "investigator_title": "md", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The change from baseline in plasma IL-6, TNF a and IL-1b level in septic patients at 7 days will be measured by ELISA.", 
            "measure": "change from baseline in plasma IL-6, TNF a and IL-1b level in septic patients at 7 days", 
            "safety_issue": "Yes", 
            "time_frame": "7 days"
        }, 
        "source": "Central South University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Central South University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}